BridgeBio Pharma Inc vs Check Point Software Technologies Ltd — how do they compare? BridgeBio Pharma Inc trades at $83.9 (market cap $16.36B), while Check Point Software Technologies Ltd trades at $129.01 (market cap $13.18B). The key difference: BridgeBio Pharma Inc is the larger of the two by market cap, and BridgeBio Pharma Inc is trading nearer its 52-week high, Check Point Software Technologies Ltd nearer its low. Which is the better fit depends on your goals.
| BBIO | CHKP | |
|---|---|---|
Market Cap | $16.36B | $13.18B |
Sector | Health | Technology |
52-Week High | $90.17 | $206.91 |
52-Week Low | $47.29 | $112.47 |
Enterprise Value | $18.14B | $12.88B |
Trailing returns across standard periods
Latest headlines on both assets
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →Check Point is a global leader in cybersecurity solutions. It provides comprehensive protection against advanced cyber threats for corporate networks, cloud environments, mobile devices, and critical infrastructure.
Read more on CHKP →